Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Ketamine therapy shows promise for alcohol and depression in early trial

NCT ID NCT07247370

First seen Jan 04, 2026 · Last updated May 01, 2026 · Updated 17 times

Summary

This early-stage study tests whether adding ketamine to talk therapy is safe and helpful for people who have both alcohol use disorder and major depression. Twenty adults will receive ketamine doses along with cognitive behavioral therapy. The main goals are to see if the treatment is feasible and safe, and to measure changes in drinking and mood.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER (MDD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Drug Health Services, Royal Prince Alfred Hospital

    Sydney, New South Wales, 2050, Australia

    Contact Phone: •••-•••-••••

    Contact Email: •••••@•••••

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.